[go: up one dir, main page]

ZA879253B - Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids,new intermediate products,processes for their preparation and their use in medicaments - Google Patents

Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids,new intermediate products,processes for their preparation and their use in medicaments

Info

Publication number
ZA879253B
ZA879253B ZA879253A ZA879253A ZA879253B ZA 879253 B ZA879253 B ZA 879253B ZA 879253 A ZA879253 A ZA 879253A ZA 879253 A ZA879253 A ZA 879253A ZA 879253 B ZA879253 B ZA 879253B
Authority
ZA
South Africa
Prior art keywords
tetrahydronaphthyloxy
medicaments
processes
preparation
intermediate products
Prior art date
Application number
ZA879253A
Other languages
English (en)
Inventor
Niewoehner Ulrich
Hoever Franz-Peter
Lieb Folker
Rosentreter Ulrich
Perzborn Elisabeth
Fiedler Volker-Bernd
Seuter Friedel
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of ZA879253B publication Critical patent/ZA879253B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA879253A 1986-12-10 1987-12-09 Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids,new intermediate products,processes for their preparation and their use in medicaments ZA879253B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642105 DE3642105A1 (de) 1986-12-10 1986-12-10 Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ZA879253B true ZA879253B (en) 1988-06-09

Family

ID=6315835

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879253A ZA879253B (en) 1986-12-10 1987-12-09 Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids,new intermediate products,processes for their preparation and their use in medicaments

Country Status (15)

Country Link
US (2) US4868332A (no)
EP (1) EP0270929A3 (no)
JP (1) JPS63165362A (no)
KR (1) KR880007434A (no)
CN (1) CN87107427A (no)
AU (1) AU601787B2 (no)
DE (1) DE3642105A1 (no)
DK (1) DK646387A (no)
FI (1) FI875397A (no)
HU (1) HU197723B (no)
IL (1) IL84724A0 (no)
NO (1) NO166177C (no)
NZ (1) NZ222820A (no)
PH (1) PH24509A (no)
ZA (1) ZA879253B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel
GB8924755D0 (en) * 1989-11-02 1989-12-20 Bayer Ag Iso-and heterocyclic phenylsulphonylamides
US5264458A (en) * 1989-11-02 1993-11-23 Bayer Aktiengesellschaft Antithrombotic iso- and heterocyclic phenylsulphonamides
US5206428A (en) * 1989-11-16 1993-04-27 Tanabe Seiyaku Co., Ltd. Tetrahydronaphthalene derivatives and preparation thereof
JPH04334358A (ja) * 1991-05-02 1992-11-20 Ono Pharmaceut Co Ltd 縮合ベンゼンオキシ酢酸誘導体
US5177106A (en) * 1991-06-21 1993-01-05 Warner-Lambert Company 4-amino substituted phenoxyalkyl carboxylic acid, ester, and alcohol derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5344836A (en) * 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
DE69410956T2 (de) * 1993-12-09 1999-03-25 Ono Pharmaceutical Co. Ltd., Osaka Naphthylessigsäurederivate als PGEZ Agonisten und Antagonisten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL285498A (no) * 1961-11-14
JPS561305B2 (no) * 1972-12-18 1981-01-13
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3207086A1 (de) * 1981-03-02 1982-11-04 Abbott Laboratories, 60064 North Chicago, Ill. Aminoalkylsubstituierte 1,2,3,4-tetrahydronaphthaline und diese enthaltende zusammensetzungen
GB8528398D0 (en) * 1985-11-19 1985-12-24 Glaxo Group Ltd Chemical compounds
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ222820A (en) 1990-11-27
IL84724A0 (en) 1988-05-31
NO166177B (no) 1991-03-04
NO874888L (no) 1988-06-13
HU197723B (en) 1989-05-29
EP0270929A2 (de) 1988-06-15
CN87107427A (zh) 1988-06-22
KR880007434A (ko) 1988-08-27
AU601787B2 (en) 1990-09-20
DK646387D0 (da) 1987-12-09
FI875397A0 (fi) 1987-12-08
HUT45972A (en) 1988-09-28
AU8241687A (en) 1988-06-16
US4868332A (en) 1989-09-19
NO166177C (no) 1991-06-12
PH24509A (en) 1990-07-18
DK646387A (da) 1988-06-11
JPS63165362A (ja) 1988-07-08
DE3642105A1 (de) 1988-06-16
US4886898A (en) 1989-12-12
NO874888D0 (no) 1987-11-24
FI875397A (fi) 1988-06-11
EP0270929A3 (de) 1990-04-25

Similar Documents

Publication Publication Date Title
IL93954A0 (en) 5-alkylquinolonecarboxylic acids,their preparation and medicaments containing them
IL78569A (en) Substituted carboxamido-benz-heterocyclyl-methyl-benzoic acids,process for their preparation and pharmaceutical compositions comprising them
IL84863A (en) 3-aryloxy-3-substituted propanamines,process for their preparation and pharmaceutical compositions comprising them
EP0259804A3 (en) Pyridoû3,2,1-ij¨-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process
DE3662104D1 (en) 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments
CS246191A3 (en) Corticoid-17-alkylcarbonates, being substituted in position 17, process of their preparation and medicaments comprising them
HUT46645A (en) Process for producing alpha-halogen-dicarboxylic acids and their derivatives and pharmaceutical compositions comprising the same
ZA88754B (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation,their use and pharmaceutical products based on these compounds
ZA875043B (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA879253B (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids,new intermediate products,processes for their preparation and their use in medicaments
PT85910A (en) Piperidin-4-yl-tetracyclic benzodiazepines a process for their preparation and their use as medicaments
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
ZA866683B (en) Dihydropyridine-2-hydroxyamines,process for their preparation and their use in medicaments
ZA888234B (en) New fluoromethoxyphenyl dihydropyridines,processes for the preparation and their use in medicaments
ZA856595B (en) New,1,4-dishydropyridines,processes for their preparation,and their use in medicaments
ZA878881B (en) Medicaments based on derivatives of 3,4-diphenylpiperidine,the use of the derivatives as medicaments,and novel 3,4-diphenylpiperidine derivatives and a process for the preparation thereof
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
ZA878324B (en) New 2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticals
ZW12286A1 (en) New benzamides,process for their preparation and their application in the pharmaceutical field
ZA856735B (en) Novel pseudooligosaccharides with an alpha-glucosidase-inhibiting action,a process for their preparation,their use and pharmaceutical products
DE3664768D1 (en) 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives, preparation process and medicinal use
ZA858249B (en) 1,4-dihydropyridine-hydroxyamines,a process for their preparation and their use in medicaments
GB2186570B (en) 9,10-dihydro-phenanthrene derivatives and process for their preparation
PT81880B (en) (1,2,4-oxadiazol-3-yl)-arymethanones a process for their preparation and their use as medicaments
ZA888235B (en) New fluoromethoxyphenyl dihydropyridines,processes for their preparation and their use in medicaments